IRB Brasil stock reports R$456 million Q3 loss after tax write-down
Invivyd stock: Q3 revenue rises as net loss widens
EPR Properties stock closes $575 million notes offering
Illumina stock: Clinical demand supports 25% Q4 margin guide
1-800-FLOWERS.COM stock: Nov. 5 Q1 report sets outlook
Hapvida stock: Q3 revenue rises 3.9%, adjusted EBITDA falls 33.5%
Incyte stock: Company halts planned Phase 3 ovarian study
Intercontinental Exchange stock: Argus raises target to USD 198
CGI stock reports 20.8% net earnings growth in fiscal Q4
Datavault AI stock faces Nasdaq suspension, OTC trading shift
James River Group stock posts $189.4 million Q3 net loss
Constellation Brands stock: Nelson's Green Brier sale reshapes spirits portfolio
Lufthansa Hedges Thin Out as Pilot Deadline and Fuel Math Collide
Dexcom stock outlook lifts as record 2026 patient growth seen
Faeth Therapeutics stock as Roche joins PIKTOR breast cancer trial
GPGI stock faces lower 2026 EBITDA guidance after Q3 results
Compass Diversified stock: Bond amendments finalized after vote
AES stock gets final FERC approval for USD 33.4 billion deal
Jet.AI stock posts wider Q3 loss as AI infrastructure pivot advances
Alexandria Real Estate stock adds NYSE Texas listing
Eastman Chemical stock: Q3 sales rise as 2026 outlook holds
AllianceBernstein stock: BofA cuts target to USD 34, keeps Underperform
Gap stock: Board declares USD 0.175 fourth-quarter dividend
Axalta stock: Merger filing outlines AkzoNobel pro forma figures
CMS Energy stock: Consumers Energy appoints transformation chief
Barrick Mining stock targets C$5.8 million Hercules investment
International Money Express stock challenges Western Union merger exit
IRIDEX stock: Revenue falls 19%, 2026 outlook cut
Peabody Energy stock: UBS upgrades rating but cuts target
Barclays sets USD 76 target while keeping Buy on Cognex stock
Ball stock: Zacks lifts fiscal 2026 EPS estimate to 4.00 dollars
Jasper Therapeutics stock: Q3 net loss reaches USD 144.5 million
EverQuote stock: Revenue goal moves to one-to-two-year horizon
Cue Biopharma stock follows Q3 revenue drop and wider net loss
CareCloud stock: New RCM deals expand AI-led growth strategy